CADM4 and neoplasm: Similar to these results, a decrease in or loss of expression of CADM4 in tumor cells was associated with aggressive clinicopathological phenotypes and poor prognosis, suggesting the potential of CADM4 as a tumor suppressor [10,12,13,14,15,16,17,18].